International Biotechnology Trust’s Zogenix, Inc. ZGNX Stock Holding History

International Biotechnology Trust’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-135,000	Closed	-$2.19M	–	81
2021 Q4	$2.19M	Hold	135,000	–	–	0.49%	43
2021 Q3	$2.05M	Buy	+135,000	New	+$2.11M	0.49%	39
2020 Q3	–	Sell	-236,832	Closed	-$6.17M	–	58
2020 Q2	$6.17M	Sell	236,832 -44,965	-16%	-$1.24M	2.05%	19
2020 Q1	$6.96M	Buy	281,797 +239,097	+560%	+$8.71M	3.17%	12
2019 Q4	$2.22M	Buy	42,700 +28,300	+197%	+$1.3M	0.8%	30
2019 Q3	$577K	Hold	14,400	–	–	0.27%	50
2019 Q2	$687K	Sell	14,400 -78,600	-85%	-$3.17M	0.25%	59
2019 Q1	$5.11M	Hold	93,000	–	–	1.89%	21
2018 Q4	$2.66M	Sell	93,000 -17,000	-15%	-$696K	1.65%	21
2018 Q3	$4.18M	Buy	+110,000	New	+$5.6M	1.99%	19

International Biotechnology Trust's ZGNX Position: Q1 2022 in Review

International Biotechnology Trust sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 135,000 shares — an estimated $2.19M sold.

International Biotechnology Trust first reported a position in ZGNX in Q3 2018 and held it in 10 quarters. The position peaked at $6.96M in Q1 2020. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

International Biotechnology Trust reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
International Biotechnology Trust sold 135,000 Zogenix, Inc. shares in Q1 2022, an estimated $2.19M.
International Biotechnology Trust first reported a position in Zogenix, Inc. in Q3 2018 and held it in 10 quarters.
International Biotechnology Trust's Zogenix, Inc. position peaked at $6.96M in Q1 2020.
0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on International Biotechnology Trust's 13F filing for Q1 2022, filed 20 May 2022.